<code id='59C6A76A3A'></code><style id='59C6A76A3A'></style>
    • <acronym id='59C6A76A3A'></acronym>
      <center id='59C6A76A3A'><center id='59C6A76A3A'><tfoot id='59C6A76A3A'></tfoot></center><abbr id='59C6A76A3A'><dir id='59C6A76A3A'><tfoot id='59C6A76A3A'></tfoot><noframes id='59C6A76A3A'>

    • <optgroup id='59C6A76A3A'><strike id='59C6A76A3A'><sup id='59C6A76A3A'></sup></strike><code id='59C6A76A3A'></code></optgroup>
        1. <b id='59C6A76A3A'><label id='59C6A76A3A'><select id='59C6A76A3A'><dt id='59C6A76A3A'><span id='59C6A76A3A'></span></dt></select></label></b><u id='59C6A76A3A'></u>
          <i id='59C6A76A3A'><strike id='59C6A76A3A'><tt id='59C6A76A3A'><pre id='59C6A76A3A'></pre></tt></strike></i>

          Home / fashion / leisure time

          leisure time


          leisure time

          author:entertainment    Page View:2
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In